BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8781658)

  • 1. A comparative study of acute and chronic diseases induced by two subgroups of Theiler's murine encephalomyelitis virus.
    Tsunoda I; Iwasaki Y; Terunuma H; Sako K; Ohara Y
    Acta Neuropathol; 1996; 91(6):595-602. PubMed ID: 8781658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus.
    Tsunoda I; Kurtz CI; Fujinami RS
    Virology; 1997 Feb; 228(2):388-93. PubMed ID: 9123847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of Theiler's murine encephalomyelitis virus (TMEV) VP1 carboxyl region on the virus-induced central nervous system disease.
    Senkowski A; Shim B; Roos RP
    J Neurovirol; 1995 Mar; 1(1):101-10. PubMed ID: 9222346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early infection of the central nervous system by the GDVII and DA strains of Theiler's virus.
    Aubert C; Brahic M
    J Virol; 1995 May; 69(5):3197-200. PubMed ID: 7707550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theiler's virus strain-dependent induction of innate immune responses in RAW264.7 macrophages and its influence on viral clearance versus viral persistence.
    Steurbaut S; Rombaut B; Vrijsen R
    J Neurovirol; 2007; 13(1):47-55. PubMed ID: 17454448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B.
    Tsunoda I; Wada Y; Libbey JE; Cannon TS; Whitby FG; Fujinami RS
    J Virol; 2001 Aug; 75(16):7494-505. PubMed ID: 11462022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent infection of RAW264.7 macrophages with the DA strain of Theiler's murine encephalomyelitis virus: An in vitro model to study viral persistence.
    Steurbaut S; Rombaut B; Vrijsen R
    J Neurovirol; 2006 Apr; 12(2):108-15. PubMed ID: 16798672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of neurovirulence of Theiler's murine encephalomyelitis virus strain GDVII is not sufficient to establish persistence in the central nervous system.
    Lipton HL; Pritchard AE; Calenoff MA
    J Gen Virol; 1998 May; 79 ( Pt 5)():1001-4. PubMed ID: 9603314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of sialyloligosaccharide binding in Theiler's virus persistence.
    Zhou L; Lin X; Green TJ; Lipton HL; Luo M
    J Virol; 1997 Dec; 71(12):9701-12. PubMed ID: 9371636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity.
    Jnaoui K; Minet M; Michiels T
    J Virol; 2002 Aug; 76(16):8138-47. PubMed ID: 12134019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct comparison of demyelinating disease induced by the Daniel's strain and BeAn strain of Theiler's murine encephalomyelitis virus.
    Zoecklein LJ; Pavelko KD; Gamez J; Papke L; McGavern DB; Ure DR; Njenga MK; Johnson AJ; Nakane S; Rodriguez M
    Brain Pathol; 2003 Jul; 13(3):291-308. PubMed ID: 12946019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L* protein of the DA strain of Theiler's murine encephalomyelitis virus is important for virus growth in a murine macrophage-like cell line.
    Takata H; Obuchi M; Yamamoto J; Odagiri T; Roos RP; Iizuka H; Ohara Y
    J Virol; 1998 Jun; 72(6):4950-5. PubMed ID: 9573263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular determinants of Theiler's murine encephalomyelitis-induced disease.
    Jakob J; Roos RP
    J Neurovirol; 1996 Apr; 2(2):70-7. PubMed ID: 8799198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct cell death mechanisms by Theiler's murine encephalomyelitis virus (TMEV) infection in microglia and macrophage.
    Ohara Y; Himeda T; Asakura K; Sawada M
    Neurosci Lett; 2002 Jul; 327(1):41-4. PubMed ID: 12098496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurovirulence of the DA and GDVII strains of Theiler's virus correlates with their ability To infect cultured neurons.
    Jarousse N; Syan S; Martinat C; Brahic M
    J Virol; 1998 Sep; 72(9):7213-20. PubMed ID: 9696815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses.
    Nitayaphan S; Toth MM; Roos RP
    J Virol; 1985 Feb; 53(2):651-7. PubMed ID: 2578578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory role of CD1d in neurotropic virus infection.
    Tsunoda I; Tanaka T; Fujinami RS
    J Virol; 2008 Oct; 82(20):10279-89. PubMed ID: 18684818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An attenuated variant of the GDVII strain of Theiler's virus does not persist and does not infect the white matter of the central nervous system.
    Jarousse N; Viktorova EG; Pilipenko EV; Agol VI; Brahic M
    J Virol; 1999 Jan; 73(1):801-4. PubMed ID: 9847392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strains from both Theiler's virus subgroups encode a determinant for demyelination.
    Fu J; Rodriguez M; Roos RP
    J Virol; 1990 Dec; 64(12):6345-8. PubMed ID: 2243399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different strains of Theiler's murine encephalomyelitis virus antagonize different sites in the type I interferon pathway.
    Stavrou S; Feng Z; Lemon SM; Roos RP
    J Virol; 2010 Sep; 84(18):9181-9. PubMed ID: 20610716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.